Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0002110286-26-000005

Options or other derivatives

  • Chief Accounting Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lindsay Brigitte Ute · Chief Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-13 Grant or award : show line 1 in the form Stock Options +200,000 1,025,334 D
Loading xslF345X05/ownership.xml…